Structure

Physi-Chem Properties

Molecular Weight:  580.27
Volume:  597.846
LogP:  4.257
LogD:  3.286
LogS:  -4.554
# Rotatable Bonds:  9
TPSA:  122.27
# H-Bond Aceptor:  9
# H-Bond Donor:  0
# Rings:  4
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.271
Synthetic Accessibility Score:  5.339
Fsp3:  0.545
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.938
MDCK Permeability:  4.926291876472533e-05
Pgp-inhibitor:  0.999
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.013
20% Bioavailability (F20%):  0.015
30% Bioavailability (F30%):  0.84

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.123
Plasma Protein Binding (PPB):  79.61872863769531%
Volume Distribution (VD):  1.72
Pgp-substrate:  19.056684494018555%

ADMET: Metabolism

CYP1A2-inhibitor:  0.106
CYP1A2-substrate:  0.044
CYP2C19-inhibitor:  0.521
CYP2C19-substrate:  0.064
CYP2C9-inhibitor:  0.863
CYP2C9-substrate:  0.044
CYP2D6-inhibitor:  0.713
CYP2D6-substrate:  0.042
CYP3A4-inhibitor:  0.718
CYP3A4-substrate:  0.365

ADMET: Excretion

Clearance (CL):  3.237
Half-life (T1/2):  0.095

ADMET: Toxicity

hERG Blockers:  0.047
Human Hepatotoxicity (H-HT):  0.965
Drug-inuced Liver Injury (DILI):  0.952
AMES Toxicity:  0.042
Rat Oral Acute Toxicity:  0.82
Maximum Recommended Daily Dose:  0.574
Skin Sensitization:  0.083
Carcinogencity:  0.122
Eye Corrosion:  0.004
Eye Irritation:  0.022
Respiratory Toxicity:  0.968

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472394

Natural Product ID:  NPC472394
Common Name*:   KCVBKOGPGLTLNX-KQDCEKGYSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  KCVBKOGPGLTLNX-KQDCEKGYSA-N
Standard InCHI:  InChI=1S/C33H40O9/c1-17-24(37)16-23-28(39-19(3)34)27-18(2)25(42-31(38)22-12-10-9-11-13-22)14-15-33(27,8)30(41-21(5)36)29(40-20(4)35)26(17)32(23,6)7/h9-13,23,25,27-30H,2,14-16H2,1,3-8H3/t23-,25-,27-,28+,29+,30-,33+/m0/s1
SMILES:  CC1=C2C(C(C3(CCC(C(=C)C3C(C(C2(C)C)CC1=O)OC(=O)C)OC(=O)C4=CC=CC=C4)C)OC(=O)C)OC(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL339923
PubChem CID:   15378568
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0000676] Taxanes and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO24820 Taxus cuspidata Species Taxaceae Eukaryota n.a. Japan n.a. PMID[14987066]
NPO24820 Taxus cuspidata Species Taxaceae Eukaryota n.a. n.a. n.a. PMID[15844936]
NPO24820 Taxus cuspidata Species Taxaceae Eukaryota n.a. n.a. n.a. PMID[15974623]
NPO24820 Taxus cuspidata Species Taxaceae Eukaryota n.a. Japan n.a. PMID[15974623]
NPO24820 Taxus cuspidata Species Taxaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO24820 Taxus cuspidata Species Taxaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO24820 Taxus cuspidata Species Taxaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO24820 Taxus cuspidata Species Taxaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified Control = 184.0 % PMID[559295]
NPT2 Others Unspecified Control = 645.0 % PMID[559295]
NPT2 Others Unspecified Activity = 87.0 % PMID[559296]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472394 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9538 High Similarity NPC472371
0.9538 High Similarity NPC472395
0.9385 High Similarity NPC472374
0.9385 High Similarity NPC472372
0.9375 High Similarity NPC471880
0.9355 High Similarity NPC469742
0.9318 High Similarity NPC475400
0.9213 High Similarity NPC195224
0.9141 High Similarity NPC225103
0.9134 High Similarity NPC473423
0.907 High Similarity NPC473443
0.907 High Similarity NPC472388
0.9037 High Similarity NPC34012
0.9 High Similarity NPC472418
0.9 High Similarity NPC472361
0.8931 High Similarity NPC209851
0.8897 High Similarity NPC475135
0.8889 High Similarity NPC477904
0.8889 High Similarity NPC183270
0.8872 High Similarity NPC66761
0.8872 High Similarity NPC472577
0.8872 High Similarity NPC291638
0.8872 High Similarity NPC17877
0.8872 High Similarity NPC473216
0.8872 High Similarity NPC473399
0.8872 High Similarity NPC195647
0.8864 High Similarity NPC472437
0.8849 High Similarity NPC217918
0.8797 High Similarity NPC474608
0.8788 High Similarity NPC475493
0.8788 High Similarity NPC80599
0.8779 High Similarity NPC147561
0.8777 High Similarity NPC474935
0.8768 High Similarity NPC38696
0.875 High Similarity NPC473109
0.875 High Similarity NPC200592
0.875 High Similarity NPC473758
0.875 High Similarity NPC147880
0.875 High Similarity NPC473085
0.875 High Similarity NPC472547
0.875 High Similarity NPC476094
0.875 High Similarity NPC473112
0.875 High Similarity NPC184747
0.875 High Similarity NPC473060
0.875 High Similarity NPC211137
0.875 High Similarity NPC43241
0.875 High Similarity NPC48017
0.875 High Similarity NPC473081
0.875 High Similarity NPC4341
0.875 High Similarity NPC473613
0.8731 High Similarity NPC477893
0.8723 High Similarity NPC91730
0.872 High Similarity NPC89324
0.8686 High Similarity NPC16912
0.8676 High Similarity NPC475652
0.8676 High Similarity NPC210591
0.8676 High Similarity NPC214550
0.8667 High Similarity NPC472545
0.8667 High Similarity NPC472551
0.8662 High Similarity NPC197037
0.8661 High Similarity NPC473439
0.8661 High Similarity NPC300827
0.8633 High Similarity NPC470231
0.8623 High Similarity NPC472546
0.8613 High Similarity NPC97667
0.8613 High Similarity NPC90614
0.8613 High Similarity NPC171207
0.8603 High Similarity NPC183122
0.8603 High Similarity NPC39549
0.8603 High Similarity NPC283375
0.8603 High Similarity NPC475373
0.8594 High Similarity NPC473749
0.8593 High Similarity NPC477896
0.8583 High Similarity NPC473243
0.8571 High Similarity NPC471100
0.8571 High Similarity NPC471107
0.8571 High Similarity NPC127857
0.8561 High Similarity NPC270498
0.8561 High Similarity NPC177340
0.8561 High Similarity NPC475429
0.8561 High Similarity NPC191082
0.8561 High Similarity NPC139067
0.8561 High Similarity NPC147217
0.8561 High Similarity NPC477894
0.8561 High Similarity NPC246480
0.8561 High Similarity NPC473673
0.8551 High Similarity NPC27377
0.8551 High Similarity NPC291599
0.8551 High Similarity NPC41481
0.8551 High Similarity NPC472576
0.8551 High Similarity NPC224491
0.8551 High Similarity NPC118080
0.8551 High Similarity NPC87448
0.8551 High Similarity NPC97947
0.855 High Similarity NPC169913
0.8542 High Similarity NPC248265
0.8542 High Similarity NPC219419
0.8542 High Similarity NPC11588
0.8542 High Similarity NPC229545
0.8542 High Similarity NPC134685
0.8527 High Similarity NPC12016
0.8519 High Similarity NPC48929
0.8519 High Similarity NPC203486
0.85 High Similarity NPC70716
0.85 High Similarity NPC472569
0.85 High Similarity NPC125106
0.85 High Similarity NPC472573
0.85 High Similarity NPC163719
0.85 High Similarity NPC67777
0.85 High Similarity NPC25768
0.85 High Similarity NPC476974
0.85 High Similarity NPC57628
0.85 High Similarity NPC11685
0.85 High Similarity NPC95265
0.85 High Similarity NPC472570
0.85 High Similarity NPC95810
0.85 High Similarity NPC51314
0.85 High Similarity NPC188865
0.8489 Intermediate Similarity NPC182869
0.8483 Intermediate Similarity NPC114357
0.8483 Intermediate Similarity NPC155329
0.8483 Intermediate Similarity NPC259144
0.8483 Intermediate Similarity NPC21410
0.8483 Intermediate Similarity NPC473670
0.8478 Intermediate Similarity NPC275592
0.8478 Intermediate Similarity NPC100913
0.8473 Intermediate Similarity NPC275576
0.8467 Intermediate Similarity NPC184109
0.8462 Intermediate Similarity NPC254558
0.8462 Intermediate Similarity NPC7095
0.8462 Intermediate Similarity NPC472373
0.8462 Intermediate Similarity NPC112216
0.844 Intermediate Similarity NPC469349
0.844 Intermediate Similarity NPC476973
0.844 Intermediate Similarity NPC470157
0.844 Intermediate Similarity NPC472572
0.844 Intermediate Similarity NPC177940
0.844 Intermediate Similarity NPC471104
0.844 Intermediate Similarity NPC472556
0.844 Intermediate Similarity NPC200471
0.844 Intermediate Similarity NPC472571
0.844 Intermediate Similarity NPC472568
0.844 Intermediate Similarity NPC470159
0.844 Intermediate Similarity NPC174982
0.844 Intermediate Similarity NPC70403
0.844 Intermediate Similarity NPC158663
0.844 Intermediate Similarity NPC171525
0.844 Intermediate Similarity NPC96903
0.844 Intermediate Similarity NPC472575
0.844 Intermediate Similarity NPC184817
0.844 Intermediate Similarity NPC473088
0.844 Intermediate Similarity NPC29704
0.8433 Intermediate Similarity NPC470278
0.8429 Intermediate Similarity NPC163087
0.8429 Intermediate Similarity NPC131966
0.8429 Intermediate Similarity NPC95449
0.8429 Intermediate Similarity NPC191387
0.8425 Intermediate Similarity NPC217091
0.8417 Intermediate Similarity NPC266374
0.8409 Intermediate Similarity NPC473220
0.8409 Intermediate Similarity NPC470753
0.8403 Intermediate Similarity NPC51602
0.8403 Intermediate Similarity NPC101043
0.8403 Intermediate Similarity NPC306799
0.8397 Intermediate Similarity NPC471758
0.8392 Intermediate Similarity NPC81698
0.8392 Intermediate Similarity NPC250046
0.8392 Intermediate Similarity NPC60509
0.8382 Intermediate Similarity NPC471911
0.8382 Intermediate Similarity NPC153617
0.8382 Intermediate Similarity NPC4242
0.8382 Intermediate Similarity NPC329913
0.838 Intermediate Similarity NPC473602
0.8372 Intermediate Similarity NPC50872
0.837 Intermediate Similarity NPC238370
0.8369 Intermediate Similarity NPC241951
0.8369 Intermediate Similarity NPC475759
0.8369 Intermediate Similarity NPC470152
0.8369 Intermediate Similarity NPC475122
0.8367 Intermediate Similarity NPC472393
0.8357 Intermediate Similarity NPC192658
0.8345 Intermediate Similarity NPC87934
0.8345 Intermediate Similarity NPC162613
0.8345 Intermediate Similarity NPC472548
0.8333 Intermediate Similarity NPC327511
0.8333 Intermediate Similarity NPC161239
0.8333 Intermediate Similarity NPC473214
0.8333 Intermediate Similarity NPC470245
0.8333 Intermediate Similarity NPC470765
0.8333 Intermediate Similarity NPC45821
0.8333 Intermediate Similarity NPC205305
0.8333 Intermediate Similarity NPC476599
0.8333 Intermediate Similarity NPC165260
0.8333 Intermediate Similarity NPC198455
0.8322 Intermediate Similarity NPC281717
0.8309 Intermediate Similarity NPC472656
0.8298 Intermediate Similarity NPC477468
0.8296 Intermediate Similarity NPC475478
0.8288 Intermediate Similarity NPC257213
0.8288 Intermediate Similarity NPC1173

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472394 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7879 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7808 Intermediate Similarity NPD7236 Approved
0.7795 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD2182 Approved
0.7702 Intermediate Similarity NPD8368 Discontinued
0.7667 Intermediate Similarity NPD7239 Suspended
0.7625 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD7799 Discontinued
0.7561 Intermediate Similarity NPD8407 Phase 2
0.75 Intermediate Similarity NPD6287 Discontinued
0.747 Intermediate Similarity NPD8434 Phase 2
0.747 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.746 Intermediate Similarity NPD164 Approved
0.7447 Intermediate Similarity NPD7008 Discontinued
0.7432 Intermediate Similarity NPD8166 Discontinued
0.7432 Intermediate Similarity NPD4628 Phase 3
0.7426 Intermediate Similarity NPD7457 Clinical (unspecified phase)
0.7424 Intermediate Similarity NPD2629 Approved
0.7405 Intermediate Similarity NPD7094 Approved
0.7405 Intermediate Similarity NPD6858 Approved
0.7381 Intermediate Similarity NPD8361 Approved
0.7381 Intermediate Similarity NPD8360 Approved
0.7381 Intermediate Similarity NPD8435 Approved
0.7364 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7343 Intermediate Similarity NPD7961 Discontinued
0.7328 Intermediate Similarity NPD1609 Clinical (unspecified phase)
0.7293 Intermediate Similarity NPD5951 Approved
0.728 Intermediate Similarity NPD1238 Approved
0.7239 Intermediate Similarity NPD4198 Discontinued
0.7234 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.723 Intermediate Similarity NPD7702 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD7058 Phase 2
0.7215 Intermediate Similarity NPD7057 Phase 3
0.7176 Intermediate Similarity NPD2067 Discontinued
0.7153 Intermediate Similarity NPD3764 Approved
0.7143 Intermediate Similarity NPD8127 Discontinued
0.7126 Intermediate Similarity NPD8485 Approved
0.7103 Intermediate Similarity NPD8032 Phase 2
0.7103 Intermediate Similarity NPD7713 Phase 3
0.7101 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD7819 Suspended
0.7078 Intermediate Similarity NPD6273 Approved
0.7055 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD7458 Discontinued
0.7047 Intermediate Similarity NPD2438 Suspended
0.7019 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD2346 Discontinued
0.6992 Remote Similarity NPD4141 Clinical (unspecified phase)
0.698 Remote Similarity NPD3748 Approved
0.698 Remote Similarity NPD7305 Phase 1
0.6977 Remote Similarity NPD1929 Approved
0.6977 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6977 Remote Similarity NPD1930 Approved
0.6959 Remote Similarity NPD8150 Discontinued
0.6957 Remote Similarity NPD7741 Discontinued
0.695 Remote Similarity NPD3972 Approved
0.6943 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6943 Remote Similarity NPD3226 Approved
0.6939 Remote Similarity NPD2979 Phase 3
0.6912 Remote Similarity NPD690 Clinical (unspecified phase)
0.6908 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6899 Remote Similarity NPD6599 Discontinued
0.6882 Remote Similarity NPD8312 Approved
0.6882 Remote Similarity NPD8313 Approved
0.6879 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7798 Approved
0.6875 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6875 Remote Similarity NPD2066 Phase 3
0.6871 Remote Similarity NPD6663 Approved
0.6867 Remote Similarity NPD2799 Discontinued
0.6867 Remote Similarity NPD7473 Discontinued
0.6863 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6863 Remote Similarity NPD7003 Approved
0.6857 Remote Similarity NPD5125 Phase 3
0.6857 Remote Similarity NPD5126 Approved
0.6852 Remote Similarity NPD7075 Discontinued
0.685 Remote Similarity NPD3495 Discontinued
0.6835 Remote Similarity NPD9545 Approved
0.6828 Remote Similarity NPD5736 Approved
0.6815 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6803 Remote Similarity NPD2313 Discontinued
0.6802 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6794 Remote Similarity NPD5909 Discontinued
0.6781 Remote Similarity NPD6832 Phase 2
0.6776 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6772 Remote Similarity NPD1989 Approved
0.6768 Remote Similarity NPD5494 Approved
0.6765 Remote Similarity NPD6764 Approved
0.6765 Remote Similarity NPD6765 Approved
0.6763 Remote Similarity NPD7610 Discontinued
0.6761 Remote Similarity NPD1281 Approved
0.6753 Remote Similarity NPD3750 Approved
0.675 Remote Similarity NPD6386 Approved
0.675 Remote Similarity NPD6385 Approved
0.6746 Remote Similarity NPD1202 Approved
0.6738 Remote Similarity NPD17 Approved
0.6736 Remote Similarity NPD1876 Approved
0.6736 Remote Similarity NPD5667 Approved
0.6735 Remote Similarity NPD6039 Approved
0.6728 Remote Similarity NPD5402 Approved
0.6718 Remote Similarity NPD6647 Phase 2
0.6713 Remote Similarity NPD6637 Approved
0.6711 Remote Similarity NPD2796 Approved
0.671 Remote Similarity NPD6190 Approved
0.6708 Remote Similarity NPD37 Approved
0.6708 Remote Similarity NPD6801 Discontinued
0.6705 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6687 Remote Similarity NPD4380 Phase 2
0.6687 Remote Similarity NPD4965 Approved
0.6687 Remote Similarity NPD6232 Discontinued
0.6687 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6687 Remote Similarity NPD4966 Approved
0.6687 Remote Similarity NPD4967 Phase 2
0.6686 Remote Similarity NPD5844 Phase 1
0.6667 Remote Similarity NPD6355 Discontinued
0.6667 Remote Similarity NPD3025 Approved
0.6667 Remote Similarity NPD5585 Approved
0.6667 Remote Similarity NPD230 Phase 1
0.6667 Remote Similarity NPD3024 Approved
0.6667 Remote Similarity NPD7631 Approved
0.6667 Remote Similarity NPD1237 Approved
0.6646 Remote Similarity NPD6873 Phase 2
0.6645 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6645 Remote Similarity NPD4110 Phase 3
0.6644 Remote Similarity NPD6085 Phase 2
0.6644 Remote Similarity NPD2798 Approved
0.6644 Remote Similarity NPD5740 Clinical (unspecified phase)
0.6641 Remote Similarity NPD1932 Approved
0.6626 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6626 Remote Similarity NPD3817 Phase 2
0.6625 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6624 Remote Similarity NPD6799 Approved
0.6621 Remote Similarity NPD2198 Approved
0.6621 Remote Similarity NPD1283 Approved
0.6621 Remote Similarity NPD2199 Approved
0.662 Remote Similarity NPD2932 Approved
0.6614 Remote Similarity NPD5122 Clinical (unspecified phase)
0.6609 Remote Similarity NPD6784 Approved
0.6609 Remote Similarity NPD6785 Approved
0.6606 Remote Similarity NPD6234 Discontinued
0.6604 Remote Similarity NPD5403 Approved
0.6603 Remote Similarity NPD3887 Approved
0.6601 Remote Similarity NPD2531 Phase 2
0.6601 Remote Similarity NPD2935 Discontinued
0.6597 Remote Similarity NPD1608 Approved
0.6596 Remote Similarity NPD8462 Phase 1
0.6594 Remote Similarity NPD1241 Discontinued
0.6594 Remote Similarity NPD6010 Discontinued
0.6593 Remote Similarity NPD2329 Discontinued
0.6587 Remote Similarity NPD7609 Phase 3
0.6585 Remote Similarity NPD7768 Phase 2
0.6582 Remote Similarity NPD2533 Approved
0.6582 Remote Similarity NPD2534 Approved
0.6582 Remote Similarity NPD5401 Approved
0.6582 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6582 Remote Similarity NPD2532 Approved
0.6582 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6579 Remote Similarity NPD7097 Phase 1
0.6575 Remote Similarity NPD1470 Approved
0.6573 Remote Similarity NPD3023 Approved
0.6573 Remote Similarity NPD3026 Approved
0.657 Remote Similarity NPD7685 Pre-registration
0.6564 Remote Similarity NPD8455 Phase 2
0.6564 Remote Similarity NPD5761 Phase 2
0.6564 Remote Similarity NPD5760 Phase 2
0.6558 Remote Similarity NPD7266 Discontinued
0.6554 Remote Similarity NPD7055 Discontinued
0.6549 Remote Similarity NPD5691 Approved
0.6549 Remote Similarity NPD1651 Approved
0.6543 Remote Similarity NPD7411 Suspended
0.6541 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6533 Remote Similarity NPD7714 Approved
0.6533 Remote Similarity NPD7715 Approved
0.6529 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6528 Remote Similarity NPD4806 Approved
0.6528 Remote Similarity NPD4807 Approved
0.6528 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6524 Remote Similarity NPD5353 Approved
0.6519 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6513 Remote Similarity NPD3528 Clinical (unspecified phase)
0.651 Remote Similarity NPD7095 Approved
0.6503 Remote Similarity NPD5306 Approved
0.6503 Remote Similarity NPD3019 Approved
0.6503 Remote Similarity NPD5305 Approved
0.65 Remote Similarity NPD3317 Approved
0.6497 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6494 Remote Similarity NPD5404 Approved
0.6494 Remote Similarity NPD5405 Approved
0.6494 Remote Similarity NPD5408 Approved
0.6494 Remote Similarity NPD5406 Approved
0.649 Remote Similarity NPD4140 Approved
0.649 Remote Similarity NPD4307 Phase 2
0.6483 Remote Similarity NPD4878 Approved
0.6481 Remote Similarity NPD7028 Phase 2
0.6479 Remote Similarity NPD7009 Phase 2
0.6478 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6474 Remote Similarity NPD6559 Discontinued
0.6471 Remote Similarity NPD2569 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data